By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

bioTheranostics 

11025 Roselle Street
Suite 200
San Diego  California  92121  U.S.A.
Phone: 858-587-5870 Fax: 858-587-5871


SEARCH JOBS








Company News
Studies Reinforce Unique Predictive And Prognostic Abilities Of bioTheranostics’ Breast Cancer Index Molecular Test 12/9/2014 1:32:09 PM
bioTheranostics Awarded Medicare Coverage for Breast Cancer Index℠ Molecular Test 10/15/2014 10:42:31 AM
bioTheranostics Appoints Nicolas Barthelemy As President And CEO 10/6/2014 8:04:52 AM
Study Shows Use Of 20/20 GeneSystems, Inc.’ Breast Cancer Indexsm Molecular Test Substantially Lowers Medical Costs For ER+ Breast Cancer Patients Compared With Standard Management 9/11/2014 10:07:53 AM
bioTheranostics Announces Update To Its bioT3 Metastatic Cancer Solution 8/12/2014 8:26:37 AM
bioTheranostics Names Ramesh Hariharan As Vice President Of Marketing 7/23/2014 12:12:05 PM
bioTheranostics Receives Approval To Perform Breast Cancer Index Testing For Patients In State Of New York 7/16/2014 10:29:02 AM
bioTheranostics’ Cancertype ID® Molecular Test Is A Cost-Effective Approach To Standardizing Diagnosis & Improving Metastatic Cancer Care, Study Shows 7/14/2014 6:33:02 AM
bioTheranostics Announces Agreement With National PPO Network Fedmed 7/10/2014 6:23:36 AM
Head-To-Head Evidence Versus Oncotype Dx Further Demonstrates Superior Clinical Accuracy Of bioTheranostics’ Breast Cancer Index For ER+ Patients 6/3/2014 9:43:18 AM
1234
//-->